Skip to main content
Clinical Trials/CTRI/2018/04/013460
CTRI/2018/04/013460CompletedPhase 2

Comparison Of Vaginal Gauze Packing Technique With or Without Balloon In High Dose Rate Brachytherapy Of Uterine Cervical Cancer- A Crossover Randomized Controlled Trial.

Jawaharlal Institute of Postgraduate Education and Research1 site in 1 country36 target enrollmentStarted: March 28, 2017Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
36
Locations
1
Primary Endpoint
Rectal and bladder radiation doses, expressed as maximum doses received to

Study Overview

Brief Summary

This study compares vaginal gauze packing technique with or without balloon in the treatment of uterine cervical cancer using high dose rate intracavitary brachytherapy. This is a randomized controlled trial with crossover design. 36 patients will be recruited after completion of external beam radiotherapy and are eligible for intracavitary brachytherapy. They will be randomized to receive first session of brachytherapy with either the control (vaginal gauze packing alone) or experimental (combined vaginal balloon and gauze packing) techniques. For the second session of brachytherapy, patients will be crossed over. The last session of brachytherapy will not be considered as a part of the trial. CT based planning will be done and dosimetric data will be collected for the bladder and rectum. A comparison will be made for the bladder and rectal dose between the two techniques. In addition, pre and post-procedural CT scans will be done to evaluate the applicator stability.

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Participant Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 70.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • •Patients with uterine cervical cancer who have completed external beam radiotherapy and are found fit for intracavitary brachytherapy.

Exclusion Criteria

  • •Patients with an ECOG Performance status >
  • •Patients who had undergone previous pelvic surgery.
  • •Patients who had undergone previous radiation therapy.
  • •Age less than 18 years.

Outcomes

Primary Outcomes

Rectal and bladder radiation doses, expressed as maximum doses received to

Time Frame: 1st and 2nd fractions of brachytherapy

respective organ volumes of 0.5cc,1cc and 2cc, as calculated in the CT-based

Time Frame: 1st and 2nd fractions of brachytherapy

brachytherapy treatment plan.

Time Frame: 1st and 2nd fractions of brachytherapy

Secondary Outcomes

  • Rectal and bladder radiation doses, expressed as maximum doses received to(respective organ volumes of 0.5cc,1cc and 2cc, as calculated in the CT-based)

Investigators

Sponsor
Jawaharlal Institute of Postgraduate Education and Research
Sponsor Class
Research institution and hospital

Study Sites (1)

Loading locations...

Similar Trials